학술논문
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK
Document Type
Article
Author
Source
In Vaccine 19 April 2018 36(17):2300-2306
Subject
Language
ISSN
0264-410X